Latest News
MIRA Pharmaceuticals, Inc.
- MIRA Pharmaceuticals, Inc. Estimates – NASDAQ:MIRA
- Mira Pharmaceuticals reports positive preclinical data for MIRA-55
- MIRA Pharmaceuticals' Oral Pain Drug Delivered Relief Comparable to Celebrex in a Three-Week Study
- MIRA Pharmaceuticals' MIRA-55 shows pain relief in preclinical study
- Form 8K Mira Pharmaceuticals Inc For: 22 October By Investing.com
- Mira Pharmaceuticals reports positive preclinical pain study By Investing.com
- Mira Pharmaceuticals reports positive preclinical pain study By Investing.com
- MIRA Pharmaceuticals Reports MIRA-55 Matches Celecoxib in Pain Relief in 21-Day Preclinical Study
- MIRA Pharmaceuticals Q2 2026 Earnings: Pre-Revenue Loss of $0.03 Per Share as Shares Slide 3.92% - Earnings Analysis
- MIRA Pharmaceuticals Q2 2026 Earnings: Pre-Revenue Loss of $0.03 Per Share as Shares Slide 3.92%
Headlines from the last 30 days, linking to the original publishers. See all market news →